Investigation of an extended-spectrum beta-lactamase-producing Escherichia coli outbreak in a geriatrics department.

被引:0
|
作者
Cukier, L [1 ]
Lutzler, P
Bizien, A
Avril, JL
机构
[1] Hop Georges Clemenceau Lab, F-91750 Champcueil, France
[2] Hop Georges Clemenceau, Serv Gerontol 1, F-91750 Champcueil, France
来源
PATHOLOGIE BIOLOGIE | 1999年 / 47卷 / 05期
关键词
disease outbreaks; extended spectrum beta-lactamase; nosocomial infection; epidemiology;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
An outbreak of extended-spectrum beta-lactamase-producing (ESBL) Escherichia coli urinary tract infection occurred on one floor of a department of the G. Clemenceau hospital. There were nine cases from March to August 1994, all of which resolved under antimicrobial therapy. Two further cases occurred, leading to a program of routine rectal swab cultures in all patients on the floor involved (first floor). ESBL E. coli carriage was found in six patients. Follow-up rectal swabs were obtained until September 1995 from all patients on the floor who were infected or colonized with ESBL E. coli between March and October 1994. Between March and June 1995, routine rectal swabs were also obtained from the patients on the other two floors of the department. Seven other carriers were detected and also underwent follow-up rectal swabs until September 1995. Ribotyping of the strains done at the national enteric molecular typing center (Pasteur Institute, Paris) demonstrated four patterns (CM1, CM2, CM3, and CM4). The strains from the first six carriers all shared the CM1 pattern, whereas among the seven carriers detected later, four (second and third floors) had a CM1 strain and the remaining three (first floor) each had a strain of the three other ribotypes (CM2, CM3, and CM4). ESBL E. coli can be carried in the digestive tract for several months. During the outbreak, the same strain was found in all the patients, whereas a variety of strains were found after the outbreak in patients without clinical symptoms due to ESBL E. coli. Routine rectal swab cultures are useful for evaluating the extent of outbreaks. However, the only effective outbreak control measures are compliance with strict hygiene procedures (signalization, technical and geographic isolation) and appropriate antimicrobial therapy. These measures were effective at the G. Clemenceau Hospital since there have been no further cases of ESBL E. coli since they were implemented. The rectal swab program has therefore been stopped, whereas strict universal hygienic precautions are still adhered to faithfully.
引用
收藏
页码:440 / 444
页数:5
相关论文
共 50 条
  • [41] Comparing the transmission of carbapenemase-producing and extended-spectrum beta-lactamase-producing Escherichia coli between broiler chickens
    Dankittipong, Natcha
    Alderliesten, Jesse B.
    Van den Broek, Jan
    Dame-Korevaar, M. Anita
    Brouwer, Michael S. M.
    Velkers, Francisca C.
    Bossers, Alex
    de Vos, Clazien J.
    Wagenaar, Jaap A.
    Stegeman, J. Arjan
    Fischer, Egil A. J.
    [J]. PREVENTIVE VETERINARY MEDICINE, 2023, 219
  • [42] Extended-spectrum β-lactamase-producing Escherichia coli
    Sloth, Louise B.
    Hargreaves, Sally
    Nellums, Laura B.
    Nielsen, Rikke T.
    Norredam, Marie
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 405 - 405
  • [43] Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in a Turkish community
    Cakir Erdogan, Derya
    Comert, Fusun
    Aktas, Elif
    Kokturk, Furuzan
    Kulah, Canan
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (01) : 172 - 179
  • [44] Prevalence of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli in urban community wastewater
    Schmiege, Dennis
    Zacharias, Nicole
    Sib, Esther
    Falkenberg, Timo
    Moebus, Susanne
    Evers, Mariele
    Kistemann, Thomas
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2021, 785
  • [45] Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infections
    Bayraktar, Banu
    Pelit, Suleyman
    Bulut, Mehmet Emin
    Aktas, Elif
    [J]. MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2019, 53 (01): : 70 - 75
  • [46] Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients
    Rodríguez-Baño, J
    Navarro, MD
    Romero, L
    Martínez-Martínez, L
    Muniain, MA
    Perea, EJ
    Pérez-Cano, R
    Pascual, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) : 1089 - 1094
  • [47] Assessment of the presence of extended-spectrum beta-lactamase-producing Escherichia coli in eggshells and ready-to-eat products
    P. Egea
    L. López-Cerero
    M. D. Navarro
    J. Rodríguez-Baño
    A. Pascual
    [J]. European Journal of Clinical Microbiology & Infectious Diseases , 2011, 30
  • [48] Assessment of the presence of extended-spectrum beta-lactamase-producing Escherichia coli in eggshells and ready-to-eat products
    Egea, P.
    Lopez-Cerero, L.
    Navarro, M. D.
    Rodriguez-Bano, J.
    Pascual, A.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (09) : 1045 - 1047
  • [49] Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals
    Mulvey, MR
    Bryce, E
    Boyd, D
    Ofner-Agostini, M
    Christianson, S
    Simor, AE
    Paton, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) : 1204 - 1214
  • [50] In Vitro Susceptibility of piperacillin/tazobactam Against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae
    Kim, Eui-Chong
    [J]. INFECTION AND CHEMOTHERAPY, 2008, 40 (01): : 49 - 51